Capital DailyCapital Daily
Finance

Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors?

Hogan's non-discretionary sale satisfied tax withholding obligations from vesting RSUs. He retains 590,777 shares worth $9.25 million.

Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors?

Published July 14, 2026 · Category: Finance

Overview

Thomas E. Hogan, Chief Executive Officer of Cellebrite DI Ltd. (NASDAQ:CLBT), reported a sale of ~103,000 shares of common stock on July 2, 2026. SEC Form 4 filing

Transaction value based on SEC Form 4 weighted average sale price ($15.76); post-transaction value based on July 2, 2026 market close ($15.65).

Details

Cellebrite DI Ltd. is a leading provider of digital intelligence solutions with a market capitalization of $4.1 billion and TTM revenues of $496.4 million, demonstrating substantial scale within the specialized software infrastructure sector. The company maintains a strong competitive position through its comprehensive, legally compliant platform that addresses critical investigative needs across public safety, national security, and corporate sectors. With a net profit margin of approximately 14.5% on a TTM basis, Cellebrite exhibits operational efficiency and profitability while serving mission-critical applications for government and law enforcement customers worldwide.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.